Rubius Therapeutics Recaps 2021 Achievements and Outlines 2022 Objectives Across the RED PLATFORM at the 40th Annual J.P. Morgan Healthcare Conference

NEXT STORY
Next Generation Sequencing Market Research Report by Type, by Technology, by Application, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19
PREV STORY
Acerus Pharmaceuticals Announces Commercial Agreement With Verity Pharmaceuticals for the Promotion of NATESTO® in Puerto Rico
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inovio Treats First Patient in Immuno-Oncology Study for Advanced or Metastatic Bladder Cancer in Combination with Roche/Genentech’s Atezolizumab

One of three ongoing oncology combination studies coupling Inovio’s T cell enhancers with checkpoint ...

author_avatar
NASDAQ Market News

Bone Therapeutics SA completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB®

Press release Bone Therapeutics completes patient recruitment for Phase IIA Spinal Fusion study with ...

author_avatar
NASDAQ Market News

Cidara Therapeutics to Present at Two Upcoming Conferences

SAN DIEGO, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology ...

author_avatar
NASDAQ Market News